Patents by Inventor Bradly G. Wouters

Bradly G. Wouters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organotellurium Compounds, Compositions and Methods of Use Thereof
    Publication number: 20210102949
    Abstract: A compound of formula (I): as described herein and methods and uses thereof as for mass tagging a biosensor or biologically active material.
    Type: Application
    Filed: September 18, 2020
    Publication date: April 8, 2021
    Inventors: Mark Nitz, Landon J. Edgar, Bradly G. Wouters, David Hedley, Lisa M. Willis, Matthew A. Lumba, Hanuel Park, Ravi N. Vellanki
  • Organotellurium compounds, compositions and methods of use thereof
    Patent number: 10816552
    Abstract: A compound of formula (I): as described herein and methods and uses thereof as for mass tagging a biosensor or biologically active material.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: October 27, 2020
    Assignees: The Governing Council of the University of Toronto, University Health Network
    Inventors: Mark Nitz, Landon J. Edgar, Bradly G. Wouters, David Hedley, Lisa M. Willis, Matthew A. Lumba, Hanuel Park, Ravi N. Vellanki
  • Organotellurium Compounds, Compositions and Methods of Use Thereof
    Publication number: 20190250165
    Abstract: A compound of formula (I): as described herein and methods and uses thereof as for mass tagging a biosensor or biologically active material.
    Type: Application
    Filed: January 11, 2019
    Publication date: August 15, 2019
    Inventors: Mark Nitz, Landon J. Edgar, Bradly G. Wouters, David Hedley, Lisa M. Willis, Matthew A. Lumba, Hanuel Park, Ravi N. Vellanki
  • Gene signature of early hypoxia to predict patient survival
    Patent number: 7960114
    Abstract: The present invention provides methods and compositions for predicting patient responses to cancer treatment using hypoxia gene signatures. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: June 14, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Renaud G. Seigneuric, Maud H. W. Starmans, Glenn Fung, Balaji Krishnapuram, Dimitry S. A. Nuyten, Arie van Erk, Michael Gaston Magagnin, Kasper M. Rouschop, Sriram Krishnan, R. Bharat Rao, Christoffel Theodorus Anthonius Evelo, Adrian Campbell Begg, Bradly G. Wouters, Philippe Lambin
  • Knowledge-Based Proliferation Signatures and Methods of Use
    Publication number: 20110059074
    Abstract: The present invention provides methods and compositions for predicting patient responses to cancer treatment using a proliferation gene signature. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.
    Type: Application
    Filed: May 2, 2008
    Publication date: March 10, 2011
    Inventors: Maud H.W. Starmans, Balaji Krishnapuram, Ranand G. Seigneuric, Harald Steck, Dimitry S.A. Nuyten, Francesca Buffa, Adrian Lewellyn Harris, Bradly G. Wouters, Philippe Lambin, R. Bharat Rao, Sriram Krishnan
  • Gene Signature of Early Hypoxia to Predict Patient Survival
    Publication number: 20090130096
    Abstract: The present invention provides methods and compositions for predicting patient responses to cancer treatment using hypoxia gene signatures. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.
    Type: Application
    Filed: May 1, 2008
    Publication date: May 21, 2009
    Applicant: Siemens Medical Solutions USA, Inc.
    Inventors: Renaud G. Seigneuric, Maud H.W. Starmans, Glenn Fung, Balaji Krishnapuram, Dimitry S.A. Nuyten, Arie van Erk, Michael Gaston Magagnin, Kasper M. Rouschop, Sriram Krishnan, R. Bharat Rao, Christoffel Theodorus Anthonius Evelo, Adrian Campbell Begg, Bradly G. Wouters, Philippe Lambin
  • Knowledge-Based Proliferation Signatures and Methods of Use
    Publication number: 20080286273
    Abstract: The present invention provides methods and compositions for predicting patient responses to cancer treatment using a proliferation gene signature. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.
    Type: Application
    Filed: May 1, 2008
    Publication date: November 20, 2008
    Applicant: Siemens Medical Solutions USA, Inc.
    Inventors: Maud H.W. Starmans, Balaji Krishnapuram, Renaud G. Seigneuric, Harald Steck, Dimitry S.A. Nuyten, Francesca Meteora Buffa, Adrian Lewellyn Harris, Bradly G. Wouters, Philippe Lambin, R. Bharat Rao, Sriram Krishnan